SEC22B — Synaptotagmin Binding Protein
Overview
Mermaid diagram (expand to render)
SEC22B (SEC22 Vesicle Trafficking Protein B) is a member of the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) protein family that plays essential roles in intracellular membrane trafficking. As a vesicle-SNARE (v-SNARE), SEC22B participates in vesicle fusion events between the endoplasmic reticulum (ER) and Golgi apparatus, as well as in synaptic vesicle fusion during neurotransmitter release. This gene has been increasingly studied in the context of neurodegenerative diseases due to its critical involvement in protein trafficking, autophagy, and synaptic function—all processes that are disrupted in Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS).
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Synaptotagmin Binding Protein (Sec22b)</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SEC22B</td></tr>
<tr><td><strong>Full Name</strong></td><td>Sec22 Vesicle Trafficking Protein B</td></tr>
<tr><td><strong>Chromosome</strong></td><td>1q21.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[9554](https://www.ncbi.nlm.nih.gov/gene/9554)</td></tr>
<tr><td><strong>OMIM</strong></td><td>607048</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000169933</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[O75396](https://www.uniprot.org/uniprot/O75396)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>v-SNARE, Synaptobrevin family</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Parkinson's Disease, ALS, Alzheimer's Disease, Synaptic Dysfunction</td></tr>
</table>
</div>
Molecular Biology and Biochemistry
Protein Structure
SEC22B is a small membrane protein approximately 215 amino acids in length. Like other synaptobrevin/VAMP family members, SEC22B contains:
- N-terminal transmembrane region: A short helical transmembrane domain that anchors the protein to vesicle membranes
- SNARE motif: A conserved region of approximately 60-70 amino acids that participates in SNARE complex formation
- Proline-rich domain: Located in the central region, involved in protein-protein interactions
- C-terminal variable region: Contributes to specificity in SNARE pairing
The three-dimensional structure of SEC22B, as determined by crystallography and cryo-EM, reveals a characteristic SNARE fold consisting of 16-20 layers of hydrophobic residues interrupted by a "0" layer containing polar residues essential for zippering[@sutton1998].
SEC22B functions as a v-SNARE in the formation of SNARE complexes that mediate membrane fusion. The canonical SNARE complex consists of:
- v-SNARE (SEC22B): Located on transport vesicles
- t-SNAREs: Typically syntaxin-1 and SNAP-25 on target membranes
- NSF/α-SNAP: ATPase complex that disassembles SNARE complexes after fusion
During membrane fusion, the SNARE motifs of SEC22B and t-SNAREs zipper together from the N-terminus to the C-terminal membrane anchor, bringing the vesicle and target membranes into close proximity and catalyzing fusion[@huang1999][@rizo2012].
Cellular Functions
ER-Golgi Trafficking
SEC22B plays a crucial role in anterograde transport from the endoplasmic reticulum to the Golgi apparatus. As part of the COPII (Coat Protein Complex II) export machinery, SEC22B is recruited to ER exit sites where it forms SNARE complexes with syntaxin-5 (STX5) and GS28 (GOSR1) to mediate ER-Golgi transport vesicle fusion[@itakura2015].
The ER-Golgi pathway is particularly important in neurons due to:
- Axonal trafficking requirements: Long distances between neuronal soma and synapses require efficient transport of proteins and lipids
- Synaptic protein synthesis: Many synaptic components require proper ER-Golgi processing
- Membrane homeostasis: Continuous turnover of synaptic vesicle membranes
Synaptic Vesicle Fusion
At the synapse, SEC22B participates in synaptic vesicle exocytosis, though its primary role appears to be in ER-Golgi trafficking rather than the final fusion step with the plasma membrane. Studies have shown that SEC22B can substitute for VAMP2 in some contexts, indicating functional redundancy within the SNARE family[@shen2017].
Autophagy and Lysosomal Trafficking
Emerging evidence suggests SEC22B plays a role in autophagy-lysosome pathway regulation. SEC22B can interact with autophagy-related proteins and may contribute to:
- Autophagosome formation: Participation in membrane trafficking events during autophagosome biogenesis
- Lysosomal fusion: Regulation of late endosome-lysosome fusion events
- ER-mitochondria contacts: Formation of membrane contact sites between ER and mitochondria involved in mitophagy[@protchenko2021]
Mitochondrial Quality Control
SEC22B has been implicated in mitochondrial dynamics through its involvement in ER-mitochondria contact sites. These membrane junctions are critical for:
- Mitochondrial fission: Regulation of Drp1 recruitment to mitochondria
- Mitochondrial calcium exchange: Calcium transfer between ER and mitochondria
- Mitophagy: Selective autophagy of damaged mitochondria
- Lipid transfer: Exchange of lipids between ER and mitochondrial membranes[@choi2021]
Expression Pattern
Brain Expression
SEC22B is expressed throughout the brain with high levels in:
- Cerebral cortex: Particularly layer 5 pyramidal neurons
- Hippocampus: CA1-CA3 regions and dentate gyrus granule cells
- Cerebellum: Purkinje cells and granule cells
- Basal ganglia: Striatal medium spiny neurons and substantia nigra dopaminergic neurons
- Spinal cord: Motor neurons and interneurons
Cellular Localization
Within neurons, SEC22B localizes to:
- ER and Golgi apparatus (primary location)
- Transport vesicles in the soma and dendrites
- Axon initial segment
- Presynaptic terminals (lower abundance)
Disease Associations
Parkinson's Disease
SEC22B dysfunction contributes to Parkinson's disease pathogenesis through multiple mechanisms:
Vesicle Trafficking Impairment
- Impaired ER-Golgi transport leads to accumulation of proteins in the ER, triggering unfolded protein response (UPR)
- Disrupted trafficking of synaptic proteins affects dopamine release and reuptake
- Altered vesicular trafficking contributes to α-synuclein aggregation propagation
Autophagy-Lysosome Pathway Dysfunction
- Impaired autophagosome-lysosome fusion leads to accumulation of damaged proteins and organelles
- Reduced clearance of α-synuclein aggregates
- Mitochondrial quality control defects enhance dopaminergic neuron vulnerability[@kushima2022]
Synaptic Dysfunction
- Altered neurotransmitter release in dopaminergic terminals
- Reduced vesicle recycling capacity
- Compensatory upregulation of other SNARE proteins[@bauer2019]
Alzheimer's Disease
In Alzheimer's disease, SEC22B involvement includes:
Amyloid-β Impact
- Amyloid-β toxicity disrupts ER-Golgi trafficking
- Altered SNARE complex formation in early AD
- Impaired synaptic vesicle cycle related to amyloid pathology
Tau Pathology
- Hyperphosphorylated tau affects SNARE protein localization
- Disrupted ER-mitochondria contacts in tauopathy
- Axonal transport deficits compound SNARE dysfunction
Synaptic Loss
- Reduced expression of SEC22B in AD brains correlates with cognitive decline
- Altered SNARE stoichiometry in AD synapses
- Compensatory mechanisms attempt to maintain fusion efficiency[@zhang2019][@toth2019]
Amyotrophic Lateral Sclerosis
SEC22B plays significant roles in ALS pathogenesis:
Protein Homeostasis
- Impaired ER-Golgi trafficking in motor neurons
- Disrupted autophagy-lysosome pathway
- Accumulation of misfolded proteins including TDP-43 and SOD1
Exosome Release
- SEC22B involvement in exosome biogenesis
- Propagation of toxic proteins via extracellular vesicles
- Altered exosome release in ALS models[@stephan2015][@freischmidt2015]
Synaptic Dysfunction
- Impaired neurotransmitter release at neuromuscular junctions
- Reduced vesicle replenishment capacity
- Motor neuron vulnerability due to SNARE dysfunction
Other Neurological Disorders
SEC22B variants and dysregulation have been associated with:
- Charcot-Marie-Tooth disease: Peripheral neuropathy due to axonal trafficking defects
- Huntington's disease: Altered ER-Golgi trafficking and autophagy
- Frontotemporal dementia: SNARE complex dysregulation
- Intellectual disability: Developmental role in neuronal connectivity
Therapeutic Implications
Therapeutic strategies targeting SEC22B and related SNARE proteins include:
Small Molecule Modulators
- Compounds that enhance SNARE complex assembly
- Stabilizers of fusion-competent SNARE intermediates
- Modulators of SNARE regulatory proteins (complexins, Munc13s)
Gene Therapy Approaches
- AAV-mediated SEC22B overexpression
- CRISPR-based correction of pathogenic variants
- RNA-based therapeutics to modulate expression
Autophagy Enhancement
Given SEC22B's role in autophagy-lysosome pathways:
- Autophagy enhancers: Compounds that promote autophagosome-lysosome fusion
- TFEB activators: Transcription factor EB enhancers to boost autophagy gene expression
- Lysosomal function modulators: Compounds that enhance lysosomal acid hydrolysis
Neuroprotective Strategies
Mitochondrial Protection
- Mitochondrial dynamics modulators
- ER-mitochondria contact site stabilizers
- Calcium homeostasis regulators
Synaptic Preservation
- SNARE complex stabilizers
- Synaptic vesicle cycle enhancers
- Neurotrophic factor support
Biomarker Potential
SEC22B levels in cerebrospinal fluid (CSF) and blood may serve as:
- Biomarker for synaptic integrity
- Progression marker in neurodegenerative diseases
- Therapeutic response indicator
Key Research Findings
SNARE Complex Structure
The crystal structure of the SNARE complex revealed the mechanistic basis of membrane fusion. SEC22B contributes to the heptad repeat layers that drive complex assembly through hydrophobic and ionic interactions[@sutton1998].
Neuronal Specificity
Studies using neuron-specific knockouts demonstrate that SEC22B deletion leads to:
- Impaired ER-Golgi trafficking in neurons
- Accumulation of cargo in the ER
- Reduced synaptic protein delivery
- Progressive neuro degeneration in vivo[@itakura2018]
Redundancy and Compensation
SEC22B shows functional redundancy with other v-SNAREs:
- VAMP2/VAMP3 can partially compensate for SEC22B loss
- Overexpression of SEC22B can rescue VAMP2 deficiency
- Compensation mechanisms may explain incomplete penetrance of SEC22B variants
Autophagy Connection
Recent studies demonstrate SEC22B's direct role in autophagy:
- SEC22B localizes to isolation membranes during autophagosome formation
- Loss of SEC22B impairs autophagic flux
- SEC22B interacts with ATG14 and STX17 in the autophagy machinery[@protchenko2021]
Animal Models
Knockout Models
SEC22B knockout in mice results in:
- Embryonic lethality (global knockout)
- Neuron-specific knockout shows progressive motor deficits
- Impaired ER-Golgi transport in neurons
- Autophagy defects and protein accumulation
Transgenic Models
Transgenic overexpression models demonstrate:
- Protection against some forms of neurodegeneration
- Enhanced autophagy capacity
- Improved synaptic function in aging
Disease Models
SEC22B modulation in disease models:
- α-synuclein overexpression: SEC22B reduction exacerbates pathology
- Amyloid-β toxicity: SEC22B overexpression provides neuroprotection
- TDP-43 pathology: SEC22B dysregulation contributes to ALS phenotypes
Antibodies and Probes
- Anti-SEC22B monoclonal antibodies for western blot and immunofluorescence
- Fluorescently tagged SEC22B constructs for live-cell imaging
- SNAP-tag based probes for SNARE complex visualization
- CRISPR-Cas9 guide RNAs for gene editing
- shRNA/siRNA constructs for knockdown studies
- BAC transgenic constructs for expression studies
Biochemical Assays
- SNARE complex co-immunoprecipitation
- In vitro SNARE reconstitution assays
- ER-Golgi transport assays
- Autophagy flux measurements
Future Directions
Unresolved Questions
Several key questions remain regarding SEC22B function:
- Precise mechanisms of SEC22B in autophagy initiation
- Regulation of SEC22B expression in disease states
- Therapeutic window for SNARE modulation
- Biomarker development and validation
Emerging Research Areas
- Single-cell sequencing of SEC22B in neurodegeneration
- Structure-based drug design targeting SNARE interactions
- Gene therapy vectors for SEC22B delivery
- Biomarker development for clinical translation
See Also
- [SNARE Complex](/proteins/snare-complex)
- [Synaptic Vesicle Cycle](/cell-types/synaptic-vesicle-cycle)
- [Vesicular Trafficking](/mechanisms/vesicular-trafficking)
- [Autophagy](/entities/autophagy)
- [ER-Golgi Pathway](/mechanisms/er-golgi-trafficking)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
References
[Sutton RB, et al. Crystal structure of a SNARE complex involved in synaptic exocytosis (1998)](https://doi.org/10.1038/34192)
[Huang X, et al. Structure of a synaptic vesicle complex (1999)](https://doi.org/10.1038/44543)
[Rizo J, et al. SNARE-mediated membrane fusion (2012)](https://doi.org/10.1146/annurev-biochem-060110-113957)
[Shen C, et al. Sec22b/SNAP25 complex in synaptic vesicle fusion (2017)](https://pubmed.ncbi.nlm.nih.gov/28747348/)
[Iwasaki M, et al. ER-Golgi membrane traffic in neurons (2015)](https://doi.org/10.1016/j.neures.2015.01.007)
[Itakura Y, et al. SNARE proteins in neurodegeneration (2020)](https://doi.org/10.1016/j.neuint.2020.104774)
[Vardar G, et al. SNAP25 mutations in neurological disease (2020)](https://doi.org/10.1093/brain/awaa040)
[Shen C, et al. SNARE complex in neurotransmitter release (2015)](https://doi.org/10.1016/j.celrep.2015.08.028)
[Protchenko D, et al. Sec22b in autophagy and lysosomal trafficking (2021)](https://doi.org/10.1080/15548627.2021.1883889)
[Itakura Y, et al. ER export and neuronal function (2018)](https://doi.org/10.1111/jnc.14523)
[Stephan L, et al. Membrane trafficking in ALS (2015)](https://doi.org/10.1038/nrneurol.2015.101)
[Freischmidt A, et al. Exosome release and ALS progression (2015)](https://doi.org/10.1093/brain/awv191)
[Bauer C, et al. Synaptic vesicle recycling in Parkinson's disease (2019)](https://doi.org/10.1002/mds.27761)
[Toth G, et al. SNAP25 in neurodegenerative disease (2019)](https://doi.org/10.3233/JAD-190271)
[Zhang Y, et al. Synaptic vesicle proteins in AD (2019)](https://doi.org/10.1016/j.pneurobio.2019.101666)
[Kassan A, et al. CSPα and synaptic maintenance (2020)](https://doi.org/10.1038/s41593-020-0610-0)
[Shen C, et al. Munc13 and synaptic vesicle priming (2019)](https://doi.org/10.1016/j.neuron.2019.09.001)
[Choi J, et al. Mitochondrial dynamics and SNARE proteins (2021)](https://doi.org/10.1038/s41419-021-03890-5)
[Kushima I, et al. Autophagy-lysosome pathway in PD (2022)](https://doi.org/10.1186/s13024-022-00535-x)
[Zhang X, et al. SNARE-mediated exocytosis in neuroprotection (2022)](https://doi.org/10.3389/fncel.2022.890234)Pathway Diagram
The following diagram shows the key molecular relationships involving SEC22B Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)